[Effectiveness of dehydroergotoxin (Ergocomb) in patients with severe craniocerebral trauma]

[Article in German]

[Article in German]

B Mühlnickel et al. Anaesthesiol Reanim. 1987.

. 1987;12(1):35-9.

No abstract available

Similar articles

Review of clinical studies with ergots in gerontology.
Venn RD. Venn RD. Adv Biochem Psychopharmacol. 1980;23:363-77. Adv Biochem Psychopharmacol. 1980. PMID: 7395623 No abstract available.
[Review of certain antagonists of peroxidation of membrane lipids by free radicals in the therapy of acute cerebrovascular accidents of ischemic origin].
Cahn J, Borzeix MG, Akimjak JP, Angignard J, Labos M, Lebeau M. Cahn J, et al. Agressologie. 1982;23(C):21-9. Agressologie. 1982. PMID: 6812445 French. No abstract available.
[Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics].
Mercier C. Mercier C. J Pharm Belg. 1982 Jul-Aug;37(4):289-98. J Pharm Belg. 1982. PMID: 6754905 Review. French. No abstract available.
[FOLLOW-UP TREATMENT OF CEREBROCRANIAL INJURIES WITH HYDERGINE].
AMANN E, GERSTENBRAND F. AMANN E, et al. Acta Neurochir (Wien). 1964;11:751. Acta Neurochir (Wien). 1964. PMID: 14213902 German. No abstract available.
Indomethacin: a review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients.
Slavik RS, Rhoney DH. Slavik RS, et al. Neurol Res. 1999 Jul;21(5):491-9. Neurol Res. 1999. PMID: 10439431 Review.